Pharma news

Reset all filters
Geography
Company
Refine search
Tough year ahead as generics take bite out of market: Teva
Asia
Israel-based Teva has predicted 2019 will be a tough year, with lower revenue and profit, as the company faces generic competition for two of its top-selling drugs.   14 February 2019
Boehringer Ingelheim teams up with IBM to explore blockchain
Americas
The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.   13 February 2019
Roche agrees to pay $21m to settle Enzo infringement suit
Americas
Swiss pharmaceutical company Roche Diagnostics has agreed to pay $21 million as part of a settlement to a patent infringement case with New York-based Enzo Biochem.   12 February 2019
Asia
The lobby group for India’s pharma industry has asked the US Trade Representative office to remove India from its Priority Watch List of places that have weak enforcement of intellectual property laws.   12 February 2019
Pharma
UK patients could be more exposed to counterfeit medicines than EU patients in the event of a ‘no deal’ Brexit, because access to an initiative aimed at protecting patients from fake drugs could be lost.   12 February 2019
Americas
The US Court of Appeals for the Federal Circuit yesterday dismissed an appeal by Massachusetts-based biotech Momenta Pharmaceuticals in a case involving a rheumatoid arthritis drug.   8 February 2019
Americas
A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.   6 February 2019
Americas
UK headquartered GSK has made another move in the oncology space, signing a potential €3.7 billion immunotherapy deal with Germany-based Merck KGaA.   6 February 2019
Americas
Rivals of British pharmaceutical company Indivior will soon be able to sell generic versions of opioid addiction treatment Suboxone film following a ruling of the US Court of Appeals for the Federal Circuit.   5 February 2019
Pharma
The Philippines Food and Drug Administration has issued a closure notice for a company allegedly responsible for producing counterfeit rabies vaccines.   4 February 2019